- Home
- PMEC vs ANL Comparison
PMEC vs ANL Comparison
Compare PMEC & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | PMEC | ANL |
|---|---|---|
| Founded | 1984 | 2004 |
| Country | Singapore | Cayman Islands |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.4M | 325.5M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PMEC | ANL |
|---|---|---|
| Price | $0.72 | $7.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 188.1K | ★ 215.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $0.88 |
| 52 Week High | $2.44 | $12.09 |
Technical Indicators
Market Signals| Indicator | PMEC | ANL |
|---|---|---|
| Relative Strength Index (RSI) | 38.95 | 47.12 |
| Support Level | $0.60 | $7.21 |
| Resistance Level | $1.11 | $9.98 |
| Average True Range (ATR) | 0.07 | 1.05 |
| MACD | 0.01 | -0.31 |
| Stochastic Oscillator | 24.72 | 25.68 |
Price Performance
Historical ComparisonAbout PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.